ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,640.50
4.50 (0.28%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  4.50 0.28% 1,640.50 1,640.00 1,640.50 1,656.00 1,635.00 1,642.00 5,918,538 16:29:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.71 67.54B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,636p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £67.54 billion. Gsk has a price to earnings ratio (PE ratio) of 13.71.

Gsk Share Discussion Threads

Showing 15026 to 15050 of 33100 messages
Chat Pages: Latest  604  603  602  601  600  599  598  597  596  595  594  593  Older
DateSubjectAuthorDiscuss
15/9/2017
15:07
Tim3 many thanks.
action
15/9/2017
14:51
Alp, the vaccine is being questioned in terms of effectiveness, again!.
I'm taking a view that something is hopefully better than nothing.

essentialinvestor
15/9/2017
14:47
Monty it was north of £15 for starters..but then u weee busy getting your vaccine:)
badtime
15/9/2017
14:15
Essential - take care. "The flu hit Australia harder than it should have this year because the most common strain appears to have mutated since it was formulated into the vaccine, with Britain set to face the same problem".
alphorn
15/9/2017
13:56
Got my flu vaccine booked, with what's happened in Australia not
skipping it this year.

Expected low 1450's on this type of FX move.

essentialinvestor
15/9/2017
13:52
When as it gone north? lol. Forget about vaccines etc, its all down to traders and a strong pound, thats bad for the dollar earners.

1385p target .

montyhedge
15/9/2017
13:10
And Monty returns when share price heads south ..quiet as a church mouse when it goes north :)))))
badtime
15/9/2017
12:37
The positive opinion on closed triple is helping moderate the decline, somewhat.
GSK have high hopes for this. It was odds on to be approved,
however to see concrete evidence is good.

essentialinvestor
15/9/2017
11:44
Action If share goes sub £14.60 will be lowest its been for 15 months.
tim 3
15/9/2017
11:27
Thought there might be an opportunity today we mentioned yesterday,
had a small amount, surprised it's not lower.

essentialinvestor
15/9/2017
11:11
The strong pound will kill the FTSE 100 run.
montyhedge
15/9/2017
11:06
I do not understand why this one voing down even after brokers r upgrade
action
15/9/2017
11:03
Tim3 what is 15 month low pls?
action
15/9/2017
10:33
romeike
No they are not bonds, but when you know what dividend you will get every year, I can tell you all being well the GSK dividend in two years will be 80p.
Its like a bond I said. Ord shares dividends should go up not stay the same for years.

NY Boy
1385p. If the pound strengthens.

montyhedge
15/9/2017
10:27
Lol Monty what price you looking for to get back in?
ny boy
15/9/2017
10:26
If 1460 support goes we are looking at 15 month lows,good value imo.
tim 3
15/9/2017
10:12
Monty - again a totally idiotic statement. You really are special.

GSK shares are patently not bonds.

romeike
15/9/2017
09:21
Trouble is this share is really a bond with double the risk, GSK Corporate bond about 4%.
Ord share roughly 5% dividend, pays 80p every year, never goes up or down so to me a bond.
But could be cut, corporate bond price stays the same and virtually guarantee.

montyhedge
15/9/2017
08:38
Expecting a blue finish today.
marine boy
15/9/2017
08:22
Hoped for lower this m9rning.
essentialinvestor
15/9/2017
08:18
Regulatory applications have been submitted and are undergoing assessment in a number of other countries, including the US, Australia and Canada. FF/UMEC/VI is an investigational medicine not yet approved for use as a single inhaler triple therapy anywhere in the world. The proposed trade name ‘Trelegy Ellipta’ is subject to regulatory approval.
tradermichael
15/9/2017
08:17
Positive newsflow will 0vertake currency exchamge variations:



GlaxoSmithKline (LSE:GSK)
Intraday Stock Chart

Today : Friday 15 September 2017

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for fluticasone furoate/ umeclidinium/vilanterol (FF/UMEC/VI) as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist (for effects on symptom control see section 5.1). The proposed brand name is Trelegy Ellipta.

tradermichael
15/9/2017
08:04
1395p possible if £ continues strong.
montyhedge
15/9/2017
08:03
Sterling of course took dollar earners up, now to take them back down. £ stronger.
montyhedge
14/9/2017
19:48
One thing when I had my shingles vac last week, the doctor said it's a live vaccination, I noticed GSK is not live.I don't know the difference.
montyhedge
Chat Pages: Latest  604  603  602  601  600  599  598  597  596  595  594  593  Older

Your Recent History

Delayed Upgrade Clock